Fractional flow reserve technology combined with computed tomographic angiography (FFRCT) offers a reliable, non-invasive source of blood flow measurements.

Although finerenone does not reduce NT-proBNP more than currently approved drugs, it may offer increased heart protection.

Researchers found no benefit in using Bioabsorbable Cardiac Matrix treatment in patients who sustained a heart attack when compared with a saline placebo.

Researchers have developed an algorithm for a rapid, 1-hour troponin I assessment to more quickly and accurately diagnose acute MIs in emergency department patients compared with the existing 3-hour assay.

In the phase 3 CIRCUS trial, the immunosuppressant drug cyclosporine held no benefits for patients who sustained ST-segment elevation myocardial infarctions.

Midday naps were associated with decreased blood pressure and heart-damage rates in patients with hypertension.

Prolonged television watchers have an increased risk of pulmonary embolism mortality.